Avid Bioservices Inc (CDMO)

[BCS Paladin]

Sounds like there will be several small open label I-O combo P1 trials producing patient data across a few different cancer indications. Certainly they'll be much faster than large P2 and P3 trials.

And still 5-7 years before we have any chance to actually sell something.

Thank goodness for AVID, our saving grace. LOL